"The Pharmaceutical Gelatin Market was valued at $ 1.85 billion in 2026 and is projected to reach $ 3.11 billion by 2034, growing at a CAGR of 6.73%."
The Pharmaceutical Gelatin Market remains a core part of the pharmaceutical excipients and capsule-material landscape because gelatin continues to support some of the most widely used oral and specialty dosage forms in the industry. Its primary applications are concentrated in hard capsules, soft gelatin capsules, tablet binding and coating, granulation, microencapsulation, and selected hemostatic and specialized delivery uses. The material remains highly valued for film-forming ability, capsule-shell performance, compatibility with powders, granules, liquids, and semi-solids, and its role in protecting fill materials from oxygen, moisture, light, and handling stress. One of the strongest current trends is the continued importance of capsule-based delivery in both prescription and over-the-counter formulations, especially where manufacturers value swallowability, dosing convenience, and formulation flexibility. Softgel development is also reinforcing demand because gelatin remains especially well suited to liquid and semi-solid fills, while hard-capsule applications continue to benefit from broad acceptance in mainstream oral drug delivery.
From a competitive standpoint, the market is shaped by global gelatin producers, capsule-material specialists, and dosage-form suppliers competing on purity, bloom strength, viscosity control, traceability, regulatory compliance, and performance consistency in pharmaceutical processing. A major growth driver is the continued reliance on oral solid and semi-solid delivery systems that demand efficient shell formation, stable dissolution behavior, and scalable manufacturing performance. Another notable trend is the increasing focus on application-specific pharmaceutical grades, faster-release and controlled-release development, and closer alignment between gelatin functionality and evolving formulation needs. At the same time, the market is becoming more quality- and supply-sensitive, with buyers placing stronger emphasis on documentation, global sourcing reliability, and fit-for-purpose material performance. Overall, the outlook remains favorable because gelatin continues to combine established regulatory acceptance, manufacturing familiarity, and broad dosage-form versatility, even as suppliers respond to changing formulation demands and competitive pressure from alternative capsule materials.
| Global Gelatin, in any form incl. sheets, surface-worked or coloured, Exports, USD million, 2020-24 | |||||
|
| 2020 | 2021 | 2022 | 2023 | 2024 |
| World | 6.49 | 6.12 | 7.35 | 8.26 | 6.23 |
| Germany | 8.48 | 8.57 | 9.44 | 11.27 | 9.18 |
| Brazil | 6.17 | 5.87 | 7.83 | 8.73 | 5.77 |
| China | 5.37 | 5.68 | 6.99 | 7.07 | 5.87 |
| France | 6.95 | 5.75 | 7.64 | 10.28 | 7.44 |
| Belgium | 6.65 | 5.37 | 6.79 | 8.51 | 5.27 |
| Source: OGAnalysis, International Trade Centre (ITC) | |||||
Germany, Brazil, China, France and Belgium are the top five countries importing 538.1% of global Gelatin, in any form incl. sheets, surface-worked or coloured in 2024
Global Gelatin, in any form incl. sheets, surface-worked or coloured Imports decreased by 4% between 2020 and 2024
Germany accounts for 147.4% of global Gelatin, in any form incl. sheets, surface-worked or coloured trade in 2024
Brazil accounts for 92.6% of global Gelatin, in any form incl. sheets, surface-worked or coloured trade in 2024
China accounts for 94.2% of global Gelatin, in any form incl. sheets, surface-worked or coloured trade in 2024
| Global Gelatin, in any form incl. sheets, surface-worked or coloured Import Prices, USD/Ton, 2020-24 |
|
|
| Source: OGAnalysis |
North America Pharmaceutical Gelatin Market is supported by strong pharmaceutical manufacturing, high capsule consumption, advanced nutraceutical production, and established demand for excipients used in hard capsules, softgels, tablet coating, and biomedical applications. Market dynamics are shaped by strict quality expectations, regulatory compliance, strong contract manufacturing activity, and rising demand for prescription drugs, over-the-counter products, vitamins, and dietary supplements. Lucrative opportunities exist for gelatin suppliers offering pharmaceutical-grade purity, traceable sourcing, customized bloom strength, low-endotoxin grades, and reliable technical support for capsule and drug delivery manufacturers. Latest trends include demand for clean-label supplements, advanced softgel formulations, improved capsule stability, and greater focus on supply-chain transparency. The forecast outlook remains favorable as pharmaceutical production, nutraceutical innovation, and biomedical applications continue expanding across the region.
Asia Pacific Pharmaceutical Gelatin Market is expanding rapidly due to strong growth in pharmaceutical manufacturing, rising healthcare access, increasing generic drug production, and expanding dietary supplement consumption. Market dynamics are supported by large-scale capsule manufacturing, cost-efficient production ecosystems, growing contract development and manufacturing activity, and rising demand for gelatin-based hard capsules and softgels. The region offers significant opportunities for gelatin producers, capsule manufacturers, nutraceutical companies, excipient suppliers, and pharmaceutical exporters serving both domestic and international markets. Latest trends include localization of pharmaceutical excipient supply, increased quality certification, growing demand for customized gelatin grades, and expanding use in functional supplements and traditional medicine-based capsules. The forecast remains positive as regional healthcare demand, manufacturing capacity, and regulated pharmaceutical exports continue strengthening.
Europe Pharmaceutical Gelatin Market is shaped by mature pharmaceutical industries, high regulatory standards, strong excipient quality requirements, and established demand for safe, traceable, and compliant gelatin products. Market dynamics are influenced by advanced capsule manufacturing, nutraceutical innovation, biomedical research, and growing demand for pharmaceutical gelatin in oral dosage forms, hemostatic products, wound care, and drug delivery systems. Lucrative opportunities exist for suppliers offering high-purity gelatin, validated sourcing documentation, customized technical grades, sustainability-focused production, and strong compliance with pharmaceutical standards. Latest trends include emphasis on traceability, animal-origin documentation, clean-label supplement formats, low-endotoxin gelatin, and development of specialized biomedical gelatin grades. The forecast outlook remains steady as European companies continue prioritizing product safety, regulatory readiness, and performance consistency.
Middle East & Africa Pharmaceutical Gelatin Market is developing steadily, supported by growth in healthcare infrastructure, increasing pharmaceutical imports, expanding local drug manufacturing, and rising consumption of capsules, softgels, vitamins, and wellness supplements. Market dynamics vary across the region, with the Middle East showing stronger demand for pharmaceutical-grade excipients and premium nutraceutical products, while Africa presents opportunities through improving access to essential medicines and growing local packaging and formulation activities. Companies can benefit by offering compliant gelatin grades, halal-aligned sourcing options, technical documentation, and reliable distribution support for pharmaceutical and supplement manufacturers. Latest trends include increasing preference for certified ingredients, growth in capsule-based medicines, expansion of nutraceutical retail, and stronger focus on quality assurance. The forecast remains constructive as regional pharmaceutical capacity and healthcare access continue improving.
South & Central America Pharmaceutical Gelatin Market is gaining momentum through expanding pharmaceutical production, rising demand for generic medicines, growth in dietary supplements, and increasing use of capsule and softgel dosage forms. Market dynamics are shaped by healthcare modernization, growing pharmacy retail, contract manufacturing development, and demand for reliable excipients that support cost-effective drug and supplement production. Opportunities exist for gelatin suppliers, capsule manufacturers, pharmaceutical formulators, nutraceutical brands, and distributors offering consistent quality, technical support, and regulatory documentation. Latest trends include rising use of gelatin capsules in vitamins and herbal supplements, stronger interest in softgel formats, improved quality-control practices, and gradual adoption of specialized pharmaceutical gelatin grades. The forecast outlook remains positive as regional manufacturers strengthen production capability and expand access to regulated dosage forms.
| Parameter | Pharmaceutical Gelatin Market Detail |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Market Size-Units | USD billion |
| Market Splits Covered | By Type, By Function, By Source, By Application |
| Countries Covered | North America (USA, Canada, Mexico) |
| Analysis Covered | Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies |
| Customization | 10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed |
| Post-Sale Support | 4 analyst hours, available up to 4 weeks |
| Delivery Format | The Latest Updated PDF and Excel Data file |
By Type
- Type A
- Type B
By Function
- Stabilizing Agent
- Thickening Agent
- Gelling Agent & other function
By Source
- Porcine
- Bovine Skin
- Bovine Bone
- Marine
- Poultry
By Application
- Hard Capsules
- Softgel Capsules
- Tablets
- Absorbable Hemostats
- Other Applications
By Geography
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
GELITA AG, Rousselot (Darling Ingredients Inc.), PB Leiner (Tessenderlo Group), Nitta Gelatin Inc., Weishardt Holding SA, LAPI Gelatine S.p.A., Italgelatine S.r.l., Trobas Gelatine B.V., Sterling Gelatin (Sterling Biotech), India Gelatine & Chemicals Ltd., Funingpu Biotechnology, Gelco International, Xiamen Gelken Gelatin Co. Ltd., Lonza (Capsugel), Catalent Pharma Solutions, Norland Products Inc., I gelatine SA, Gelnex Pharmaceuticals, Bio‑Gelatin GmbH, Eastman Chemical Company.
July 2025 – Gelita AG expanded its pharmaceutical-grade gelatin production facility in Germany to meet rising global demand for high-purity gelatin used in softgel capsules and specialty drug delivery systems.
June 2025 –Nitta Gelatin announced the development of a new pharmaceutical gelatin grade with enhanced solubility and improved dissolution properties, targeting high-precision therapeutic applications.
May 2025 – PB Leiner launched an eco-friendly pharmaceutical gelatin line focused on sustainable sourcing and low environmental impact, aligned with the growing demand for green manufacturing in drug formulations.
April 2025 – Sterling Gelatin commissioned a new production line in India dedicated to BSE-free pharmaceutical gelatin, aiming to cater to regulated export markets and support India's expanding capsule manufacturing sector.
March 2025 –Rousselot introduced a pharmaceutical gelatin portfolio designed for rapid-dissolution capsules, enhancing bioavailability for active pharmaceutical ingredients across multiple therapeutic areas.
The Pharmaceutical Gelatin Market is estimated to reach USD 3.1 billion by 2034.
The Global Pharmaceutical Gelatin Market is estimated to generate USD 1.85 billion in revenue in 2026.
The Global Pharmaceutical Gelatin Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.73% during the forecast period from 2026 to 2034.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!